Back to search results

Immune Biomarker Study for Head and Neck Cancer

Abroad (travel likely)Recruiting

Conditions

Head and Neck Cancer · Oral Cavity Cancer · Oropharyngeal Cancer · Hypopharyngeal Cancer · Laryngeal Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • ENT - Head and Neck Surgery Department, Erlangen, Bavaria, Germany

    Contact: Study coordinator (Antoniu-Oreste Gostian, PD Dr. med.) · antoniu-oreste.gostian@uk-erlangen.de · +49 9131 85-33156

  • Maxillo-Facial-Surgery Department, Erlangen, Bavaria, Germany

    Contact: Study coordinator (Manuel Weber, PD Dr. med.)

  • Radiation Oncology Department, Erlangen, Bavaria, Germany

    Contact: Study coordinator (Markus Hecht, PD Dr. med.)
Study leads

  • Antoniu-Oreste Gostian, PD Dr. med.

    Study Director

    ENT - Head and Neck Surgery Department, University of Erlangen-Nurnberg

  • Markus Hecht, PD Dr. med.

    Study Director

    Radiation Oncology, University of Erlangen-Nurnberg

  • Manuel Weber, PD Dr. med. Dr. med. dent.

    Principal Investigator

    Maxillo-facial-surgery, University of Erlangen-Nurnberg

  • Udo Gaipl, Prof. Dr. rer. nat. habil.

    Principal Investigator

    Translational Radiobiology, University of Erlangen-Nurnberg

  • Benjamin Frey, PD Dr.-Ing. Dr. habil. med.

    Principal Investigator

    Translational Radiobiology, University of Erlangen-Nurnberg

View source on ClinicalTrials.gov(opens in a new tab)